A slower rate of infusion for the 1st DARZALEX® dose is usually recommended, as infusion reactions usually tend to manifest during the first infusion2 These are definitely biological products that have by now been approved through the FDA, versus which biosimilar merchandise are when compared. There is one for daratumumab. https://adhdozempic.com/